Zazabie s.r.o.
- Address
- lock Available on a paid plan
Zazabie s.r.o. - Autoimmune Disease Research Center
Zazabie s.r.o. is a clinical research facility dedicated to advancing the treatment of complex autoimmune conditions. The center specializes in conducting comprehensive investigations of novel therapeutic agents, with particular expertise in evaluating both short-term efficacy and long-term safety outcomes in patients with systemic autoimmune disorders.
- Systemic Lupus Erythematosus (SLE) treatment optimization and long-term safety monitoring
- Evaluation of oral JAK inhibitors and immunomodulatory therapies in moderate to severe disease
- Extended follow-up studies assessing disease activity changes and adverse event profiles
The center's research portfolio includes participation in multi-phase clinical programs, ranging from Phase 3 efficacy trials through long-term extension studies. With a focus on moderately to severely active autoimmune diseases, Zazabie s.r.o. contributes valuable data on safety and efficacy endpoints that help define optimal treatment strategies for patients requiring advanced immunosuppressive therapies and background medication management.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Novartis Pharma AG1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Zazabie s.r.o.
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Pharmacokinetic and Safety Study of Bimekizumab via Different Routes of Administration in Adults with Chronic Cutaneous Inflammation | UCB Biopharma | Phase I | Recruiting | Apr 2026 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Emtricitabine | 2 | Unknown | 2023-02-03 | 2024-05-21 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.